Prostate — Recruiting

The NINJA clinical trial aims to compare two emerging schedules of radiotherapy in the treatment of intermediate or high risk prostate cancer. Participants will be randomly assigned to one of two radiotherapy schedules as part of this study. In schedule 1 (called Stereotactic Body Radiotherapy) participants will receive 5 radiotherapy treatments over 2 weeks, and in schedule 2, (called Virtual High Dose Rate Boost), participants will receive Stereotactic Body Radiotherapy delivered in 2 treatments over 1 week followed by 12 treatments of conventional external beam radiotherapy over 2 and a half weeks. It is hoped this research will potentially improve the accuracy and quality of radiotherapy treatment in prostate cancer.
If you think this trial might be right for you, please ask your doctor.
If you think this trial might be right for you, please ask your doctor.
Trial Title
Novel Integration of new prostate radiation therapy schedules with adjuvant androgen deprivation
Cancer Type
Trial Status
Protocol Number
TROG 18.01
Study Chair
Associate Professor Jarad Martin and Dr Mark Sidhom
Patient Population
Prostate cancer
Detailed Information
Participating Centres
Calvary Mater Newcastle
Campbelltown Hospital - South Western Sydney Local Health District
GenesisCare Newcastle
Genesiscare Hurstville
Liverpool Hospital - South Western Sydney Local Health District
Illawarra Cancer Centre
St George Hospital - South Eastern Sydney Local Health District (SESLHD)
Westmead Hospital - Western Sydney Local Health District
Blacktown Hospital
GenesisCare Maitland

Peter MacCallum Cancer Centre

Princess Alexandra Hospital

Genesiscare South Australia
Royal Adelaide Hospital - Central Adelaide Local Health Network Inc.

5D clinics
Genesiscare Fiona Stanley Hospital
Sir Charles Gairdner Hospital 

Waikato General Hospital